If anything qualifies for a 2 month review, then surely it's this. They have to review an instruction manual, and the most vanilla trial in history. Agree with Beefarmer the FDA process is govt red tape at is worst. Great news and well done to management getting this done ahead of schedule.
Ann: Botanix Resubmission of NDA for Sofdra Completed, page-22
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.010(3.64%) |
Mkt cap ! $448.9M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.3¢ | 28.0¢ | $1.520M | 5.359M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 28852 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 399879 | 4 |
View Market Depth
| Last trade - 16.10pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
0.010 ( 2.89 %) |
||||
| Open | High | Low | Volume | ||
| 28.3¢ | 29.0¢ | 27.8¢ | 3154311 | ||
| Last updated 15.59pm 12/06/2024 ? | |||||
| BOT (ASX) Chart |